Skip to content skip to primary navi skip to secondary navi skip to meta navi search

Publications 2007

Original Papers

  • Ansell SM, Horwitz SM, Engert A, Khan KD, Lin T, Strair R, Keler T, Graziano R, Blanset D, Yellin M, Fischkoff S, Assad A, Borchmann P. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol. 2007; 25(19):2764-9.
  • Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007 Feb 10;25(5):579-86.
  • Eich HT, Gossmann A, Engert A, Kriz J, Bredenfeld H, Hansemann K, Skripnitchenko R, Brillant C, Pfistner B, Staar S, Diehl V, Müller R-P. A contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma - analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG). Int J Radiat Oncol Biol Phys. 2007; 69 (4):1187-92.
  • Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Witt M, Theophil B, Dörken B, Boissevain F, Hänel A, Paulus U, Hasenclever D, Löffler M, Müller R-P, Müller-Hermelink HK, Dühmke E, Diehl V. Two cycles of ABVD plus extended field radiotherapy is superior to radiotherapy alone in early-favourable Hodgkin’s lymphoma: Final results of the GHSG HD7 trial. J Clin Oncol. 2007; 10; 25 (23):3495-3502. [FINAL ANALYSIS HD7]
  • Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber  WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD. Use of Positron Emission Tomography (PET) for Response Assessment of Lymphoma: Consensus Recommendations of the Imaging Subcommittee of the International Harmonization Project (IHP) in Lymphoma. J Clin Oncol 2007; 25(2): 571-578.
  • Klimm B, Eich HT, Haverkamp H, Herrmann R, Koch P, Boissevain F, De Witt M, Mezger J, Dühmke E, Müller R-P, Müller-Hermelink K, Pfistner B, Diehl V, Engert A. Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin lymphoma: An analysis from the German Hodgkin Study Group. Ann Oncol 2007; 18 (2):357-363.
  • Sieniawski M. Franklin J. Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma J Clin Oncol 2007; 25: 2000-5.
  • Trelle S, Sezer O, Naumann R, Rummel M, Keller U, Engert A, Borchmann P. Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018). Haematologica. 2007; 92(4):568-9.


  • Aleman BM, Re D, Diehl V. The role of radiation therapy in patients with Hodgkin's lymphoma. Curr Hematol Malig Rep. 2007 Jul;2(3):151-60. 
  • Diehl V, Engert A, Re D. New strategies for the treatment of advanced-stage Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007; 21(5):897-914.
  • Diehl V, Engert A, Re D. Hodgkin's lymphoma: new insights in an old disease. Preface. Hematol Oncol Clin North Am. 2007; 21(5): xiii-xiv. No abstract available.
  • Diehl, V.Fuchs, M. Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies. Ann Oncol 2007, 18 Suppl 9, ix71-9 
  • Diehl V, Fuchs M; GHSG. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages? Transfus Apher Sci. 2007 Aug;37(1):37-41.
  • Diehl V. Hodgkin's disease--from pathology specimen to cure. N Engl J Med. 2007 Nov 8;357(19):1968-71.
  • Klimm B, Diehl V, Engert A. Hodgkin's lymphoma in the elderly: a different disease in patients over 60. Oncology (Williston Park). 2007; 21(8):982-90
  • Klimm B, Engert A. Therapiekonzepte beim Hodgkin Lymphom. Klinische Onkologie 2007/2008, 2007; 4:27-33.